NUZ — Neurizon Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$33.22m
- AU$26.89m
Brief: Pharmaust Appoints Sergio Duchini As Non-Executive Chairman
Brief: Pharmaust Ltd Says Sam Wright Has Been Appointed Interim Chairman Of Pharmaust
Brief: Pharmaust Ltd Seeks Trading Halt
Brief: Pharmaust Ltd Says Chief Executive Officer Michael Thurn, Has Tendered His Resignation
Australia's PharmAust rises after approval to start study
Brief: Pharmaust Seeks Trading Halt
Brief: Pharmaust Files Positive Clinical Data With FDA To Support Orphan Drug Designation Request
Brief: Pharmaust Ltd Seeks Trading Halt
Brief: Pharmaust Says Successfully Completed A Pre-Ind Meeting With FDA
Australia's PharmAust rises on effective first patient dosing
Brief: Pharmaust Says FDA Provided Clear Feedback For ODD Approval
Australia's PharmAust hits over 3-yr high on partnering with MND specialist
Brief: Pharmaust Partners With Berry Consultants For Phase 2/3 MND Study
Australia's PharmAust hits 3-year high after FDA grants Pre-IND meeting
Brief: Pharmaust Says US FDA Grants Co's Pre-Ind Meeting For Monepantel For Treatment Of MND/ALS
Brief: Pharmaust Raises A$3.5 Million At A Premium
Brief: Pharmaust Seeks Trading Halt
Australia's Pharmaust hits over 4-month high on completion of Phase 1 study
Brief: Pharmaust Seeks Trading Halt